English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52669446    Online Users :  792
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"yeh h z"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-10 of 25  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-05-10T08:09:42Z Efficacy of second-line regimens for Helicobacter pylori eradication treatment: A systemic review and network meta-analysis Chang Y.-L.; Tung Y.-C.; YU-KANG TU; Yeh H.-Z.; Yang J.-C.; Hsu P.-I.; Kim S.-E.; Wu M.-F.; Liou W.-S.; Shiu S.-I.
臺大學術典藏 2022-03-04T08:22:44Z Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey) Chuah Y.-Y.; Wu D.-C.; Chuah S.-K.; JYH-CHIN YANG; Lee T.-H.; Yeh H.-Z.; Chen C.-L.; Liu Y.-H.; Hsu P.-I.
臺大學術典藏 2022-03-04T08:22:43Z Efficacy of second-line regimens for Helicobacter pylori eradication treatment: A systemic review and network meta-analysis Chang Y.-L.; Tung Y.-C.; Tu Y.-K.; Yeh H.-Z.; JYH-CHIN YANG; Hsu P.-I.; Kim S.-E.; Wu M.-F.; Liou W.-S.; Shiu S.-I.
臺大學術典藏 2022-01-24T09:32:03Z Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage CHUN-JEN LIU; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.
臺大學術典藏 2022-01-24T09:31:38Z Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence CHUN-JEN LIU; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.
臺大學術典藏 2021-09-04T06:19:01Z Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C Yang S.-S.; Fu L.-S.; Chang C.-S.; Yeh H.-Z.; Chen G.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:25Z IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients Chuang J.Y.; Yang S.S.; Lu Y.T.; Hsieh Y.Y.; Chen C.Y.; Chang S.C.; Chang C.S.; Yeh H.Z.; JIA-HORNG KAO
臺大學術典藏 2021-09-01T02:02:15Z Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; Wang H.-P.; Kuo S.-H.; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; ANN-LII CHENG
臺大學術典藏 2021-07-03T03:34:53Z Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage Liu C.-J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:06Z Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence Liu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN

Showing items 1-10 of 25  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page